Image

Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury

Recruiting
18 - 100 years of age
Both
Phase N/A

Powered by AI

Overview

A well-managed bowel program is an essential part of daily life for many people with a SCI. Nevertheless, constipation is frequently reported (42-95%). Constipation embraces a spectrum of harms including both physical & psychological distress. Initial exploratory studies suggest abdominal FES may be useful for decreasing overall bowel management time, decreasing colonic transit time and reducing discomfort. The current study will seek to reproduce previous findings in a 12 week study, using overall bowel management time as a benchmark for establishing proof of principle. The study will include 36 people with a spinal cord injury aged 18 and over with an above T12 injury, a complete or incomplete lesion in a medically stable condition, one year or more after injury. Participants will be randomised into two groups. One group will receive abdominal electrical stimulation and the other group low dose abdominal electrical stimulation. Participants will be asked to keep a bowel diary and complete questionnaires examining quality of life and bowel management.

Eligibility

  • Inclusion Criteria:
    • People with a diagnosis of spinal cord injury
    • Age =>18 years of age
    • Injury level at or above T12
    • complete or incomplete spinal cord lesion
    • Medically stable condition
    • Reflex bowel
    • =>1 year post spinal cord injury
    • Exclusion Criteria:
    • A history of organic bowel obstruction
    • Frequent opioid use,
    • Intrathecal baclofen or percutaneous endoscopic gastrostomy
    • Inflammatory bowel disease
    • Recent abdominal hernia
    • Recent gastrointestinal or abdominal surgery
    • Lower motor neuron lesions,
    • Suspected strictures or fistulae along the gastrointestinal tract
    • Physiologic gastrointestinal obstruction.
    • Other causes of constipation such as hypothyroidism, hypercalcaemia
    • Constipation predominant irritable bowel syndrome prior to diagnosis of SCI
    • Involvement in other research trial interventions likely to impact current trial
    • Poorly controlled epilepsy,
    • Cardiac pacemaker in situ
    • Other implanted electrical devices
    • Pregnancy or pregnancy planned
    • Cancerous tissue in the abdominal region
    • Any major skin disorders affecting the abdominal area)
    • Severe autonomic dysreflexia (tested at initial assessment).

Study details

Neurogenic Bowel

NCT04307303

Salisbury NHS Foundation Trust

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.